Singula Bio
Business Services · United Kingdom · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Bioescalator Innovation Building Old Roa...Website
www.singulabio.comRevenue
<$5 MillionIndustry
About Singula Bio
Is Singula Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Singula Bio has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Singula Bio
Singula Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Singula Bio recently announced quarterly report
Funding: Get notified immidiatlly once Singula Bio has new funding data
Check out if Singula Bio is spiking on competitors!
Click to see if Singula Bio had a recent Job posting/layoffs
Product Launch: Get notified when Singula Bio launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Singula Bio
Compare insights from companies similar to Singula Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Company Profile Activity
Activity Insights
Singula Bio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Singula Bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Singula Bio.
Singula Bio Tech Stack
A closer look at the technologies used by Singula Bio
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Singula Bio
Singula Bio is a seed-stage biotechnology company spun out of the University of Oxford, dedicated to developing novel neoantigen-based cell therapies for patients with solid tumors. The company aims to become a leader in individualized cancer therapies, utilizing advanced immunological, medical, surgical, and computational technologies to address c... Read More